MetaADEDB 2.0 @ LMMD
Atorvastatin
(FQCKMBLVYCEXJB-MNSAWQCASA-L)
Structure
SMILES
O[C@@H](C[C@H](CC(=O)[O-])O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccccc1.O[C@@H](C[C@H](CC(=O)[O-])O)CCn1c(C(C)C)c(c(c1c1ccc(cc1)F)c1ccccc1)C(=O)Nc1ccccc1.[Ca+2]
Molecular Formula:
C66H68CaF2N4O10
Molecular Weight:
1155.340
Log P:
10.1038
Hydrogen Bond Acceptor:
14
Hydrogen Bond Donor:
6
TPSA:
229.24
CAS Number(s):
110862-48-1; 134523-03-8; 1316891-47-0
Synonym(s)
1.
Atorvastatin
2.
(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid
3.
Atorvastatin Calcium
4.
Atorvastatin Calcium Anhydrous
5.
Atorvastatin Calcium Hydrate
6.
Atorvastatin Calcium Trihydrate
7.
Atorvastatin, Calcium Salt
8.
CI 981
9.
CI-981
10.
Lipitor
11.
Liptonorm
12.
CI981
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1MyalgiaFAERS: 3112
Canada Vigilance: 172
Canada Vigilance
US FAERS
2ArthralgiaFAERS: 977
Canada Vigilance: 27
Canada Vigilance
US FAERS
3PainFAERS: 879
Canada Vigilance: 33
Canada Vigilance
US FAERS
4Drug ineffectiveFAERS: 794
Canada Vigilance: 32
Canada Vigilance
US FAERS
5FatigueFAERS: 765
Canada Vigilance: 28
Canada Vigilance
US FAERS
6AstheniaFAERS: 730
Canada Vigilance: 21
Canada Vigilance
US FAERS
7AmnesiaFAERS: 696
Canada Vigilance: 16
Canada Vigilance
US FAERS
8Myocardial InfarctionFAERS: 668
Canada Vigilance: 46
Canada Vigilance
US FAERS
9Blood creatine phosphokinase increasedFAERS: 587
Canada Vigilance: 60
Canada Vigilance
US FAERS
10MalaiseFAERS: 586
Canada Vigilance: 26
Canada Vigilance
US FAERS
11Cerebrovascular accidentFAERS: 564
Canada Vigilance: 25
Canada Vigilance
US FAERS
12Blood cholesterol increasedFAERS: 534
Canada Vigilance: 14
Canada Vigilance
US FAERS
13RhabdomyolysisFAERS: 479
Canada Vigilance: 50
Canada Vigilance
US FAERS
14Diabetes MellitusFAERS: 393
Canada Vigilance: 29
Canada Vigilance
US FAERS
15HeadacheFAERS: 393
Canada Vigilance: 32
Canada Vigilance
US FAERS
16DizzinessFAERS: 378
Canada Vigilance: 25
Canada Vigilance
US FAERS
17NauseaFAERS: 377
Canada Vigilance: 49
Canada Vigilance
US FAERS
18Memory impairmentFAERS: 312
Canada Vigilance: 6
Canada Vigilance
US FAERS
19Back PainFAERS: 308
Canada Vigilance: 20
Canada Vigilance
US FAERS
20Feeling abnormalFAERS: 276
Canada Vigilance: 4
Canada Vigilance
US FAERS
21PruritusFAERS: 274
Canada Vigilance: 17
Canada Vigilance
US FAERS
22Weight decreasedFAERS: 251
Canada Vigilance: 17
Canada Vigilance
US FAERS
23MyopathyFAERS: 247
Canada Vigilance: 7
Canada Vigilance
US FAERS
24AlopeciaFAERS: 243
Canada Vigilance: 7
Canada Vigilance
US FAERS
25No adverse eventFAERS: 221
Canada Vigilance: 2
Canada Vigilance
US FAERS
26Blood glucose increasedFAERS: 216
Canada Vigilance: 4
Canada Vigilance
US FAERS
27Musculoskeletal PainFAERS: 214
Canada Vigilance: 10
Canada Vigilance
US FAERS
28Abdominal discomfortFAERS: 204
Canada Vigilance: 26
Canada Vigilance
US FAERS
29AbasiaFAERS: 199US FAERS
30Chest PainFAERS: 193
Canada Vigilance: 8
Canada Vigilance
US FAERS
31VomitingFAERS: 175
Canada Vigilance: 19
Canada Vigilance
US FAERS
32ConstipationFAERS: 169
Canada Vigilance: 12
Canada Vigilance
US FAERS
33Alanine Aminotransferase IncreasedFAERS: 167
Canada Vigilance: 18
Canada Vigilance
US FAERS
34Musculoskeletal stiffnessFAERS: 162
Canada Vigilance: 9
Canada Vigilance
US FAERS
35Respiratory arrestFAERS: 161US FAERS
36Aspartate Aminotransferase IncreasedFAERS: 157
Canada Vigilance: 14
Canada Vigilance
US FAERS
37HypersensitivityFAERS: 155
Canada Vigilance: 5
Canada Vigilance
US FAERS
38Blood triglycerides increasedFAERS: 153
Canada Vigilance: 7
Canada Vigilance
US FAERS
39ArthritisFAERS: 149
Canada Vigilance: 2
Canada Vigilance
US FAERS
40muscle injuryFAERS: 148
Canada Vigilance: 1
Canada Vigilance
US FAERS
41ArthropathyFAERS: 143
Canada Vigilance: 2
Canada Vigilance
US FAERS
42Emotional distressFAERS: 141
Canada Vigilance: 1
Canada Vigilance
US FAERS
43UrticariaFAERS: 138
Canada Vigilance: 8
Canada Vigilance
US FAERS
44DisorientationFAERS: 135
Canada Vigilance: 2
Canada Vigilance
US FAERS
45Low density lipoprotein increasedFAERS: 135
Canada Vigilance: 9
Canada Vigilance
US FAERS
46TremorFAERS: 133
Canada Vigilance: 7
Canada Vigilance
US FAERS
47AnxietyFAERS: 131
Canada Vigilance: 5
Canada Vigilance
US FAERS
48CataractFAERS: 126
Canada Vigilance: 6
Canada Vigilance
US FAERS
49Abdominal PainFAERS: 123
Canada Vigilance: 17
Canada Vigilance
US FAERS
50Wrong technique in drug usage processFAERS: 121US FAERS
51Activities of daily living impairedFAERS: 120US FAERS
52InfarctionFAERS: 115
Canada Vigilance: 7
Canada Vigilance
US FAERS
53PneumoniaFAERS: 111
Canada Vigilance: 3
Canada Vigilance
US FAERS
54FlatulenceFAERS: 110
Canada Vigilance: 4
Canada Vigilance
US FAERS
55DyspepsiaFAERS: 109
Canada Vigilance: 14
Canada Vigilance
US FAERS
56DysgeusiaFAERS: 107
Canada Vigilance: 1
Canada Vigilance
US FAERS
57PalpitationsFAERS: 104
Canada Vigilance: 4
Canada Vigilance
US FAERS
58ChromaturiaFAERS: 102
Canada Vigilance: 4
Canada Vigilance
US FAERS
59MyositisFAERS: 100
Canada Vigilance: 4
Canada Vigilance
US FAERS
60Neck PainFAERS: 98
Canada Vigilance: 6
Canada Vigilance
US FAERS
61DeafnessFAERS: 96
Canada Vigilance: 1
Canada Vigilance
US FAERS
62Burning sensationFAERS: 92
Canada Vigilance: 3
Canada Vigilance
US FAERS
63Visual ImpairmentFAERS: 91
Canada Vigilance: 8
Canada Vigilance
US FAERS
64Gamma-Glutamyltransferase IncreasedFAERS: 89
Canada Vigilance: 7
Canada Vigilance
US FAERS
65Erectile dysfunctionFAERS: 87
Canada Vigilance: 3
Canada Vigilance
US FAERS
66Transaminases increasedFAERS: 86US FAERS
67Limb discomfortFAERS: 85
Canada Vigilance: 1
Canada Vigilance
US FAERS
68NasopharyngitisFAERS: 85
Canada Vigilance: 1
Canada Vigilance
US FAERS
69ThrombosisFAERS: 85US FAERS
70TinnitusFAERS: 82
Canada Vigilance: 3
Canada Vigilance
US FAERS
71jaundiceFAERS: 82
Canada Vigilance: 2
Canada Vigilance
US FAERS
72HepatitisFAERS: 79
Canada Vigilance: 3
Canada Vigilance
US FAERS
73SwellingFAERS: 79
Canada Vigilance: 1
Canada Vigilance
US FAERS
74SomnolenceFAERS: 75
Canada Vigilance: 2
Canada Vigilance
US FAERS
75Amyotrophic Lateral SclerosisFAERS: 74
Canada Vigilance: 2
Canada Vigilance
US FAERS
76DementiaFAERS: 74
Canada Vigilance: 2
Canada Vigilance
US FAERS
77Cardiac ArrestFAERS: 73US FAERS
78Bone painFAERS: 72
Canada Vigilance: 2
Canada Vigilance
US FAERS
79PancreatitisFAERS: 72
Canada Vigilance: 5
Canada Vigilance
US FAERS
80Joint swellingFAERS: 71
Canada Vigilance: 3
Canada Vigilance
US FAERS
81Nerve injuryFAERS: 70US FAERS
82Blood alkaline phosphatase increasedFAERS: 69
Canada Vigilance: 7
Canada Vigilance
US FAERS
83NervousnessFAERS: 63
Canada Vigilance: 3
Canada Vigilance
US FAERS
84BlindnessFAERS: 62
Canada Vigilance: 2
Canada Vigilance
US FAERS
85Impaired work abilityFAERS: 62
Canada Vigilance: 1
Canada Vigilance
US FAERS
86ErythemaFAERS: 61
Canada Vigilance: 2
Canada Vigilance
US FAERS
87Product substitution issueFAERS: 61
Canada Vigilance: 119
Canada Vigilance
US FAERS
88Coronary Artery DiseaseFAERS: 60
Canada Vigilance: 10
Canada Vigilance
US FAERS
89GlaucomaFAERS: 58
Canada Vigilance: 2
Canada Vigilance
US FAERS
90Angina PectorisFAERS: 54
Canada Vigilance: 2
Canada Vigilance
US FAERS
91Unevaluable eventFAERS: 54
Canada Vigilance: 1
Canada Vigilance
US FAERS
92AphasiaFAERS: 53US FAERS
93Atrial FibrillationFAERS: 52US FAERS
94Chest discomfortFAERS: 52
Canada Vigilance: 1
Canada Vigilance
US FAERS
95NephrolithiasisFAERS: 52
Canada Vigilance: 1
Canada Vigilance
US FAERS
96nervous system disorderFAERS: 51US FAERS
97Blood creatinine increasedFAERS: 50
Canada Vigilance: 4
Canada Vigilance
US FAERS
98Peripheral swellingFAERS: 50
Canada Vigilance: 5
Canada Vigilance
US FAERS
99Product quality issueFAERS: 48US FAERS
100DiscomfortFAERS: 47US FAERS
101VertigoFAERS: 47
Canada Vigilance: 5
Canada Vigilance
US FAERS
102Back disorderFAERS: 46US FAERS
103Blood cholesterol abnormalFAERS: 46
Canada Vigilance: 7
Canada Vigilance
US FAERS
104DiplopiaFAERS: 46US FAERS
105Musculoskeletal discomfortFAERS: 46US FAERS
106NeuralgiaFAERS: 45
Canada Vigilance: 2
Canada Vigilance
US FAERS
107CholelithiasisFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
108DysarthriaFAERS: 43US FAERS
109FibromyalgiaFAERS: 43
Canada Vigilance: 1
Canada Vigilance
US FAERS
110Respiratory FailureFAERS: 43US FAERS
111InfluenzaFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
112Muscle FatigueFAERS: 42US FAERS
113Muscle tightnessFAERS: 42US FAERS
114Blood lactate dehydrogenase increasedFAERS: 41
Canada Vigilance: 2
Canada Vigilance
US FAERS
115DermatomyositisFAERS: 41
Canada Vigilance: 2
Canada Vigilance
US FAERS
116InfectionFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
117Urinary tract infectionFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
118DehydrationFAERS: 40
Canada Vigilance: 2
Canada Vigilance
US FAERS
119Dry skinFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
120General physical health deteriorationFAERS: 40US FAERS
121Product taste abnormalFAERS: 40US FAERS
122HypothyroidismFAERS: 39
Canada Vigilance: 1
Canada Vigilance
US FAERS
123SyncopeFAERS: 39US FAERS
124Intentional product misuseFAERS: 38US FAERS
125Joint stiffnessFAERS: 38
Canada Vigilance: 3
Canada Vigilance
US FAERS
126Mental impairmentFAERS: 38
Canada Vigilance: 3
Canada Vigilance
US FAERS
127PolymyositisFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
128TachycardiaFAERS: 38
Canada Vigilance: 1
Canada Vigilance
US FAERS
129AsthmaFAERS: 37
Canada Vigilance: 2
Canada Vigilance
US FAERS
130Cerebral InfarctionFAERS: 37US FAERS
131ChokingFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
132Joint injuryFAERS: 37US FAERS
133LethargyFAERS: 37
Canada Vigilance: 4
Canada Vigilance
US FAERS
134Rheumatoid ArthritisFAERS: 37
Canada Vigilance: 2
Canada Vigilance
US FAERS
135StressFAERS: 37US FAERS
136Drug exposure during pregnancyFAERS: 36US FAERS
137DysphoniaFAERS: 35US FAERS
138InflammationFAERS: 35US FAERS
139Limb injuryFAERS: 35US FAERS
140ChillsFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
141Myocardial necrosis marker increasedFAERS: 34US FAERS
142Myoglobin blood increasedFAERS: 34US FAERS
143OsteoporosisFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
144PolyneuropathyFAERS: 34US FAERS
145ThrombocytopeniaFAERS: 34
Canada Vigilance: 3
Canada Vigilance
US FAERS
146Autoimmune hepatitisFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
147GoutFAERS: 33
Canada Vigilance: 3
Canada Vigilance
US FAERS
148HypokinesiaFAERS: 33
Canada Vigilance: 2
Canada Vigilance
US FAERS
149Impaired driving abilityFAERS: 33US FAERS
150MonoplegiaFAERS: 33US FAERS
151Oropharyngeal painFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
152Polymyalgia RheumaticaFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
153Walking aid userFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
154CholestasisFAERS: 30US FAERS
155Drug dispensing errorFAERS: 30US FAERS
156Global AmnesiaFAERS: 30US FAERS
157Muscle enzyme increasedFAERS: 30US FAERS
158Middle insomniaFAERS: 29US FAERS
159NeuropathyFAERS: 29US FAERS
160BedriddenFAERS: 28US FAERS
161BronchitisFAERS: 28US FAERS
162Drug dose omissionFAERS: 28US FAERS
163Product size issueFAERS: 28US FAERS
164AngerFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
165Carpal Tunnel SyndromeFAERS: 27US FAERS
166Drug effect incompleteFAERS: 27US FAERS
167Medication ErrorFAERS: 27
Canada Vigilance: 2
Canada Vigilance
US FAERS
168Rotator cuff syndromeFAERS: 27US FAERS
169ArteriosclerosisFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
170Pancreatic carcinomaFAERS: 26
Canada Vigilance: 2
Canada Vigilance
US FAERS
171Throat irritationFAERS: 26US FAERS
172HypotensionFAERS: 25
Canada Vigilance: 4
Canada Vigilance
US FAERS
173Lip swellingFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
174Personality ChangeFAERS: 25US FAERS
175Renal painFAERS: 25
Canada Vigilance: 4
Canada Vigilance
US FAERS
176Blood creatine phosphokinase MB increasedFAERS: 24US FAERS
177DisabilityFAERS: 24US FAERS
178FlushingFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
179White blood cell count decreasedFAERS: 24US FAERS
180EpistaxisFAERS: 23US FAERS
181Pharmaceutical product complaintFAERS: 23US FAERS
182Therapeutic response unexpectedFAERS: 23US FAERS
183DysuriaFAERS: 22
Canada Vigilance: 2
Canada Vigilance
US FAERS
184Muscle CrampFAERS: 22US FAERS
185SinusitisFAERS: 22US FAERS
186Spinal column stenosisFAERS: 22US FAERS
187AgeusiaFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
188CryingFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
189Depressed moodFAERS: 21US FAERS
190Multiple SclerosisFAERS: 21US FAERS
191Rash erythematousFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
192SepsisFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
193Macular degenerationFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
194Musculoskeletal chest painFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
195Night sweatsFAERS: 20US FAERS
196Poor quality drug administeredFAERS: 20US FAERS
197Post procedural complicationFAERS: 20US FAERS
198Acute myocardial infarctionFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
199Blood potassium increasedFAERS: 19US FAERS
200Emotional disorderFAERS: 19US FAERS
201EpilepsyFAERS: 19US FAERS
202EructationFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
203GastritisFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
204Myasthenia GravisFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
205Product use issueFAERS: 19US FAERS
206Pulmonary FibrosisFAERS: 19US FAERS
207Suspected counterfeit productFAERS: 19US FAERS
208AngioedemaFAERS: 18
Canada Vigilance: 5
Canada Vigilance
US FAERS
209Gastric ulcerFAERS: 18US FAERS
210HyperthyroidismFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
211Incorrect dose administeredFAERS: 18US FAERS
212OverdoseFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
213Poor quality sleepFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
214Postoperative thrombosisFAERS: 18US FAERS
215Pulmonary EmbolismFAERS: 18US FAERS
216Reaction to drug excipientsFAERS: 18US FAERS
217Skin lesionFAERS: 18US FAERS
218AgitationFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
219Blood glucose decreasedFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
220CholecystitisFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
221Drug administration errorFAERS: 17US FAERS
222DysgraphiaFAERS: 17US FAERS
223Expired drug administeredFAERS: 17US FAERS
224HostilityFAERS: 17US FAERS
225Muscle strainFAERS: 17US FAERS
226Pharmaceutical product counterfeitFAERS: 17US FAERS
227Restless Legs SyndromeFAERS: 17US FAERS
228RestlessnessFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
229AnorexiaFAERS: 16US FAERS
230Intentional drug misuseFAERS: 16US FAERS
231Intervertebral disc disorderFAERS: 16US FAERS
232Medication residueFAERS: 16US FAERS
233Quality of life decreasedFAERS: 16US FAERS
234Urinary IncontinenceFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
235Visual disturbanceFAERS: 16US FAERS
236WheezingFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
237Acute Coronary SyndromeFAERS: 15US FAERS
238Aortic AneurysmFAERS: 15
Canada Vigilance: 4
Canada Vigilance
US FAERS
239Deep Vein ThrombosisFAERS: 15US FAERS
240FrustrationFAERS: 15US FAERS
241Gait inabilityFAERS: 15
Canada Vigilance: 6
Canada Vigilance
US FAERS
242HepatomegalyFAERS: 15US FAERS
243HypersomniaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
244Irritable Bowel SyndromeFAERS: 15US FAERS
245Loss of personal independence in daily activitiesFAERS: 15
Canada Vigilance: 3
Canada Vigilance
US FAERS
246Mood swingsFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
247Product use in unapproved indicationFAERS: 15US FAERS
248PsoriasisFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
249Blood urine presentFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
250Cataract operationFAERS: 14US FAERS
251Depressed Level of ConsciousnessFAERS: 14US FAERS
252EczemaFAERS: 14US FAERS
253Enzyme abnormalityFAERS: 14US FAERS
254Muscle necrosisFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
255AneurysmFAERS: 13US FAERS
256AnosmiaFAERS: 13US FAERS
257Apparent deathFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
258Blood urea increasedFAERS: 13US FAERS
259Completed SuicideFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
260Diabetes mellitus inadequate controlFAERS: 13US FAERS
261Eye painFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
262FormicationFAERS: 13US FAERS
263Hepatitis CFAERS: 13US FAERS
264HerniaFAERS: 13US FAERS
265Lupus-like syndromeFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
266LymphadenopathyFAERS: 13US FAERS
267Multi-organ disorderFAERS: 13US FAERS
268Ocular icterusFAERS: 13US FAERS
269PoisoningFAERS: 13US FAERS
270SciaticaFAERS: 13US FAERS
271Wheelchair userFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
272Acute kidney injuryFAERS: 12
Canada Vigilance: 3
Canada Vigilance
US FAERS
273Adverse eventFAERS: 12US FAERS
274AngioplastyFAERS: 12
Canada Vigilance: 4
Canada Vigilance
US FAERS
275Bilirubin conjugated increasedFAERS: 12US FAERS
276Blood creatine phosphokinase abnormalFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
277Blood pressure fluctuationFAERS: 12US FAERS
278CellulitisFAERS: 12US FAERS
279Circumstance or information capable of leading to medication errorFAERS: 12US FAERS
280Cytolytic hepatitisFAERS: 12US FAERS
281Dental cariesFAERS: 12US FAERS
282DermatitisFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
283Diabetic NephropathyFAERS: 12US FAERS
284Disease recurrenceFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
285Economic problemFAERS: 12US FAERS
286EosinophiliaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
287Feeling ColdFAERS: 12US FAERS
288Grip strength decreasedFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
289High density lipoprotein increasedFAERS: 12US FAERS
290Nephrotic SyndromeFAERS: 12US FAERS
291Poor peripheral circulationFAERS: 12US FAERS
292Product use complaintFAERS: 12US FAERS
293Productive CoughFAERS: 12US FAERS
294Therapy non-responderFAERS: 12US FAERS
295Vascular bypass graftFAERS: 12US FAERS
296Ankle FractureFAERS: 11US FAERS
297AphagiaFAERS: 11US FAERS
298AscitesFAERS: 11US FAERS
299Blood glucose abnormalFAERS: 11US FAERS
300Blood potassium decreasedFAERS: 11US FAERS
301Blood testosterone decreasedFAERS: 11US FAERS
302CystitisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
303Diabetic FootFAERS: 11US FAERS
304Disease ProgressionFAERS: 11US FAERS
305DiverticulitisFAERS: 11US FAERS
306Lipase increasedFAERS: 11US FAERS
307SluggishnessFAERS: 11US FAERS
308Urinary RetentionFAERS: 11US FAERS
309AphoniaFAERS: 10US FAERS
310HepatotoxicityFAERS: 10US FAERS
311High density lipoprotein abnormalFAERS: 10US FAERS
312Inappropriate schedule of drug administrationFAERS: 10US FAERS
313Joint Range of Motion DecreasedFAERS: 10US FAERS
314MYELODYSPLASTIC SYNDROMEFAERS: 10US FAERS
315PancytopeniaFAERS: 10US FAERS
316ParesisFAERS: 10US FAERS
317PolyuriaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
318PresyncopeFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
319Septic ShockFAERS: 10US FAERS
320Sexual DysfunctionFAERS: 10US FAERS
321Skin irritationFAERS: 10US FAERS
322ThirstFAERS: 10US FAERS
323Throat cancerFAERS: 10US FAERS
324ToothacheFAERS: 10US FAERS
325Ubiquinone decreasedFAERS: 10US FAERS
326UlcerFAERS: 10US FAERS
327VasculitisFAERS: 10US FAERS
328Venous occlusionFAERS: 10US FAERS
329AcneFAERS: 9US FAERS
330Aldolase increasedFAERS: 9US FAERS
331AsphyxiaFAERS: 9US FAERS
332Blood thyroid stimulating hormone increasedFAERS: 9US FAERS
333BursitisFAERS: 9US FAERS
334Cerebral ThrombosisFAERS: 9US FAERS
335ColitisFAERS: 9US FAERS
336CystFAERS: 9US FAERS
337Diabetic RetinopathyFAERS: 9US FAERS
338EmbolismFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
339Executive dysfunctionFAERS: 9US FAERS
340Eye irritationFAERS: 9US FAERS
341FractureFAERS: 9US FAERS
342Intervertebral Disc DegenerationFAERS: 9US FAERS
343Intestinal ObstructionFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
344LeukopeniaFAERS: 9US FAERS
345Ligament ruptureFAERS: 9US FAERS
346Mental status changesFAERS: 9US FAERS
347OnychomycosisFAERS: 9US FAERS
348OverweightFAERS: 9US FAERS
349PeriarthritisFAERS: 9US FAERS
350QuadriplegiaFAERS: 9US FAERS
351ScreamingFAERS: 9US FAERS
352Skin tightnessFAERS: 9US FAERS
353StomatitisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
354Sudden deathFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
355TensionFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
356Wrong technique in product usage processFAERS: 9US FAERS
357Acute respiratory failureFAERS: 8US FAERS
358ApathyFAERS: 8US FAERS
359Arterial therapeutic procedureFAERS: 8US FAERS
360Blood amylase increasedFAERS: 8US FAERS
361BradyphreniaFAERS: 8US FAERS
362Breast tendernessFAERS: 8US FAERS
363Cardiac FlutterFAERS: 8US FAERS
364Carotid artery occlusionFAERS: 8US FAERS
365Cold sweatFAERS: 8US FAERS
366Drug ineffective for unapproved indicationFAERS: 8US FAERS
367EcchymosisFAERS: 8US FAERS
368Expired product administeredFAERS: 8US FAERS
369Gastrointestinal PainFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
370Head discomfortFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
371Hepatic necrosisFAERS: 8US FAERS
372Lipoprotein (a) increasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
373Low density lipoprotein abnormalFAERS: 8US FAERS
374LymphomaFAERS: 8US FAERS
375MalabsorptionFAERS: 8US FAERS
376Necrotising myositisFAERS: 8
Canada Vigilance: 20
Canada Vigilance
US FAERS
377OsteomyelitisFAERS: 8US FAERS
378Panic DisorderFAERS: 8US FAERS
379Psychiatric symptomFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
380Skin UlcerFAERS: 8US FAERS
381Skin reactionFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
382Vascular occlusionFAERS: 8US FAERS
383Vitamin D DeficiencyFAERS: 8US FAERS
384Arthropod biteFAERS: 7US FAERS
385Blood sodium decreasedFAERS: 7US FAERS
386Blood triglycerides abnormalFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
387BronchopneumoniaFAERS: 7US FAERS
388Catheter placementFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
389Drug prescribing errorFAERS: 7US FAERS
390Drug toxicityFAERS: 7US FAERS
391Ear discomfortFAERS: 7US FAERS
392Gastric BypassFAERS: 7US FAERS
393Hepatic EncephalopathyFAERS: 7US FAERS
394LabyrinthitisFAERS: 7US FAERS
395Lactose IntoleranceFAERS: 7US FAERS
396LipomaFAERS: 7US FAERS
397Mouth swellingFAERS: 7US FAERS
398Pain of skinFAERS: 7US FAERS
399PetechiaeFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
400Product contamination physicalFAERS: 7US FAERS
401Product dispensing errorFAERS: 7US FAERS
402Retinal DetachmentFAERS: 7US FAERS
403ShockFAERS: 7US FAERS
404Sinus headacheFAERS: 7US FAERS
405SomnambulismFAERS: 7US FAERS
406Thymus enlargementFAERS: 7US FAERS
407Thyroid NeoplasmFAERS: 7US FAERS
408Tooth LossFAERS: 7US FAERS
409Vitreous floatersFAERS: 7US FAERS
410Amylase increasedFAERS: 6US FAERS
411AnhedoniaFAERS: 6US FAERS
412Benign Prostatic HyperplasiaFAERS: 6US FAERS
413Blood glucose fluctuationFAERS: 6US FAERS
414BradycardiaFAERS: 6US FAERS
415CarcinomaFAERS: 6US FAERS
416CardiomegalyFAERS: 6US FAERS
417Cell DeathFAERS: 6US FAERS
418Cerebellar AtaxiaFAERS: 6US FAERS
419Coronary angioplastyFAERS: 6US FAERS
420Deafness NeurosensoryFAERS: 6US FAERS
421DeliriumFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
422Drug DependenceFAERS: 6US FAERS
423Electrocardiogram abnormalFAERS: 6US FAERS
424Erection increasedFAERS: 6US FAERS
425Facial PainFAERS: 6US FAERS
426Gastrointestinal carcinomaFAERS: 6US FAERS
427HemiplegiaFAERS: 6US FAERS
428ImmobileFAERS: 6US FAERS
429Intestinal infarctionFAERS: 6US FAERS
430Intracranial AneurysmFAERS: 6US FAERS
431LaryngitisFAERS: 6US FAERS
432LeukocytosisFAERS: 6US FAERS
433Lichen PlanusFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
434Lipids abnormalFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
435MetastasisFAERS: 6US FAERS
436MetrorrhagiaFAERS: 6US FAERS
437Muscle RigidityFAERS: 6US FAERS
438Myoglobin urine presentFAERS: 6US FAERS
439NoduleFAERS: 6US FAERS
440Nonspecific reactionFAERS: 6US FAERS
441ObesityFAERS: 6US FAERS
442Optic NeuritisFAERS: 6US FAERS
443OsteopeniaFAERS: 6US FAERS
444PleurisyFAERS: 6US FAERS
445Product packaging issueFAERS: 6US FAERS
446Protein urine presentFAERS: 6US FAERS
447Quadruple vessel bypass graftFAERS: 6US FAERS
448Respiratory distressFAERS: 6US FAERS
449RetchingFAERS: 6US FAERS
450SclerodermaFAERS: 6US FAERS
451Shoulder PainFAERS: 6US FAERS
452Sjogren's SyndromeFAERS: 6US FAERS
453SneezingFAERS: 6US FAERS
454SplenomegalyFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
455Troponin increasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
456AgranulocytosisFAERS: 5US FAERS
457AppendicitisFAERS: 5US FAERS
458AtelectasisFAERS: 5US FAERS
459Atrioventricular BlockFAERS: 5US FAERS
460Autoimmune thyroiditisFAERS: 5US FAERS
461Bipolar DisorderFAERS: 5US FAERS
462Bladder painFAERS: 5US FAERS
463Blood creatine increasedFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
464Breast CystFAERS: 5US FAERS
465Bulbar palsyFAERS: 5US FAERS
466Cardiac discomfortFAERS: 5US FAERS
467CholangitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
468Creatinine renal clearance decreasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
469DiplegiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
470Feeling jitteryFAERS: 5US FAERS
471Flank PainFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
472Food AllergyFAERS: 5US FAERS
473Gallbladder painFAERS: 5US FAERS
474Gastric infectionFAERS: 5US FAERS
475GlossitisFAERS: 5US FAERS
476Hearing disabilityFAERS: 5US FAERS
477Hypoaesthesia facialFAERS: 5US FAERS
478HypogonadismFAERS: 5US FAERS
479HypophagiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
480HypoxiaFAERS: 5US FAERS
481Impaired gastric emptyingFAERS: 5US FAERS
482IncontinenceFAERS: 5US FAERS
483Limb operationFAERS: 5US FAERS
484Metabolic acidosisFAERS: 5US FAERS
485NeutropeniaFAERS: 5US FAERS
486No adverse reactionFAERS: 5US FAERS
487Ocular discomfortFAERS: 5US FAERS
488OsteitisFAERS: 5US FAERS
489PallorFAERS: 5US FAERS
490Pancreatic enzymes increasedFAERS: 5US FAERS
491PericarditisFAERS: 5US FAERS
492Peripheral arterial occlusive diseaseFAERS: 5US FAERS
493Physical disabilityFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
494PregnancyFAERS: 5US FAERS
495Procedural complicationFAERS: 5US FAERS
496Product physical issueFAERS: 5US FAERS
497ProteinuriaFAERS: 5US FAERS
498Renal cystFAERS: 5US FAERS
499RosaceaFAERS: 5US FAERS
500Stevens-Johnson SyndromeFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
501Toxicity to various agentsFAERS: 5US FAERS
502Accidental overdoseFAERS: 4US FAERS
503Alanine aminotransferase abnormalFAERS: 4US FAERS
504Alcohol abuseFAERS: 4US FAERS
505Altered state of consciousnessFAERS: 4US FAERS
506AmputationFAERS: 4US FAERS
507Ankylosing spondylitisFAERS: 4US FAERS
508Arterial bypass operationFAERS: 4US FAERS
509AsthenopiaFAERS: 4US FAERS
510Blood immunoglobulin E increasedFAERS: 4US FAERS
511Blood iron decreasedFAERS: 4US FAERS
512Blood magnesium decreasedFAERS: 4US FAERS
513Bowel movement irregularityFAERS: 4US FAERS
514BronchospasmFAERS: 4US FAERS
515Carbohydrate antigen 19-9 increasedFAERS: 4US FAERS
516Carcinoembryonic antigen increasedFAERS: 4US FAERS
517Cardiac ablationFAERS: 4US FAERS
518Cardiac procedure complicationFAERS: 4US FAERS
519Cerebral disorderFAERS: 4US FAERS
520Chronic Fatigue SyndromeFAERS: 4US FAERS
521ClumsinessFAERS: 4US FAERS
522Counterfeit drug administeredFAERS: 4US FAERS
523Device occlusionFAERS: 4US FAERS
524Diabetic KetoacidosisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
525Drug exposure before pregnancyFAERS: 4US FAERS
526DysphasiaFAERS: 4US FAERS
527DystoniaFAERS: 4US FAERS
528EncephalitisFAERS: 4US FAERS
529EpicondylitisFAERS: 4US FAERS
530EpididymitisFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
531Fear of fallingFAERS: 4US FAERS
532Gastrointestinal infectionFAERS: 4US FAERS
533Gastrointestinal sounds abnormalFAERS: 4US FAERS
534Heart valve calcificationFAERS: 4US FAERS
535HemiparesisFAERS: 4US FAERS
536Hepatic congestionFAERS: 4US FAERS
537Hip surgeryFAERS: 4US FAERS
538HyperkeratosisFAERS: 4US FAERS
539HyporeflexiaFAERS: 4US FAERS
540Increased tendency to bruiseFAERS: 4US FAERS
541Increased upper airway secretionFAERS: 4US FAERS
542Initial insomniaFAERS: 4US FAERS
543Intercepted drug dispensing errorFAERS: 4US FAERS
544Lip and/or oral cavity cancerFAERS: 4US FAERS
545Liver AbscessFAERS: 4US FAERS
546Loose toothFAERS: 4US FAERS
547Lower motor neurone lesionFAERS: 4US FAERS
548Lower respiratory tract infectionFAERS: 4US FAERS
549Lyme DiseaseFAERS: 4US FAERS
550Lymphocytic infiltrationFAERS: 4US FAERS
551Medical device complicationFAERS: 4US FAERS
552Medication residue presentFAERS: 4US FAERS
553MeningitisFAERS: 4US FAERS
554Meniscus injuryFAERS: 4US FAERS
555Multiple MyelomaFAERS: 4US FAERS
556MyocarditisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
557MyoglobinuriaFAERS: 4US FAERS
558MyosclerosisFAERS: 4US FAERS
559No adverse effectFAERS: 4US FAERS
560Obsessive thoughtsFAERS: 4US FAERS
561Ocular vascular disorderFAERS: 4US FAERS
562OnychoclasisFAERS: 4US FAERS
563Otitis MediaFAERS: 4US FAERS
564Pancreatic CystFAERS: 4US FAERS
565ParaplegiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
566PeriodontitisFAERS: 4US FAERS
567PhlebitisFAERS: 4US FAERS
568PneumothoraxFAERS: 4US FAERS
569Pre-existing condition improvedFAERS: 4US FAERS
570Prescribed overdoseFAERS: 4US FAERS
571Product counterfeitFAERS: 4US FAERS
572Product shape issueFAERS: 4US FAERS
573Profound Mental RetardationFAERS: 4US FAERS
574Pulmonary thrombosisFAERS: 4US FAERS
575Reaction to excipientFAERS: 4US FAERS
576RegurgitationFAERS: 4US FAERS
577Renal tubular necrosisFAERS: 4US FAERS
578Respiratory DepressionFAERS: 4US FAERS
579Retrograde amnesiaFAERS: 4US FAERS
580Sinus TachycardiaFAERS: 4US FAERS
581SpondylitisFAERS: 4US FAERS
582Suicide attemptFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
583Temperature intoleranceFAERS: 4US FAERS
584Transmission of drug via semenFAERS: 4US FAERS
585Trigeminal NeuralgiaFAERS: 4US FAERS
586Triple vessel bypass graftFAERS: 4US FAERS
587Venous ThrombosisFAERS: 4US FAERS
588Venous thrombosis limbFAERS: 4US FAERS
589Vitreous DetachmentFAERS: 4US FAERS
590AbscessFAERS: 3US FAERS
591Amaurosis FugaxFAERS: 3US FAERS
592Animal biteFAERS: 3US FAERS
593AnorgasmiaFAERS: 3US FAERS
594Antibody test abnormalFAERS: 3US FAERS
595AtaxiaFAERS: 3US FAERS
596Axonal neuropathyFAERS: 3US FAERS
597Basal cell carcinomaFAERS: 3US FAERS
598Biopsy liver abnormalFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
599Biopsy muscle abnormalFAERS: 3US FAERS
600Bladder spasmFAERS: 3US FAERS
601Blood count abnormalFAERS: 3US FAERS
602Blood immunoglobulin G increasedFAERS: 3US FAERS
603Blood triglycerides decreasedFAERS: 3US FAERS
604Bone density decreasedFAERS: 3US FAERS
605Bone lesionFAERS: 3US FAERS
606Buccal mucosal rougheningFAERS: 3US FAERS
607CachexiaFAERS: 3US FAERS
608Cardiomyopathy acuteFAERS: 3US FAERS
609Cubital Tunnel SyndromeFAERS: 3US FAERS
610CyanosisFAERS: 3US FAERS
611DemyelinationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
612Dengue FeverFAERS: 3US FAERS
613Depression suicidalFAERS: 3US FAERS
614Disseminated Intravascular CoagulationFAERS: 3US FAERS
615Drug withdrawal syndromeFAERS: 3US FAERS
616DysphemiaFAERS: 3US FAERS
617Electrocardiogram changeFAERS: 3US FAERS
618Enterococcal infectionFAERS: 3US FAERS
619Essential HypertensionFAERS: 3US FAERS
620Eye laser surgeryFAERS: 3US FAERS
621Failure to ThriveFAERS: 3US FAERS
622FastingFAERS: 3US FAERS
623FolliculitisFAERS: 3US FAERS
624Foreign body traumaFAERS: 3US FAERS
625Full blood count abnormalFAERS: 3US FAERS
626GastroenteritisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
627Gastrointestinal inflammationFAERS: 3US FAERS
628General physical condition abnormalFAERS: 3US FAERS
629Granulocyte count decreasedFAERS: 3US FAERS
630Guillain-Barre SyndromeFAERS: 3US FAERS
631HydronephrosisFAERS: 3US FAERS
632HyperparathyroidismFAERS: 3US FAERS
633Hypertensive heart diseaseFAERS: 3US FAERS
634HypoventilationFAERS: 3US FAERS
635Infectious peritonitisFAERS: 3US FAERS
636InfertilityFAERS: 3US FAERS
637Insulin-requiring type 2 diabetes mellitusFAERS: 3US FAERS
638Intentional dose omissionFAERS: 3US FAERS
639Intentional product use issueFAERS: 3US FAERS
640LacerationFAERS: 3US FAERS
641LymphopeniaFAERS: 3US FAERS
642Malignant neoplasm progressionFAERS: 3US FAERS
643MenorrhagiaFAERS: 3US FAERS
644Multiple System AtrophyFAERS: 3US FAERS
645Multiple allergiesFAERS: 3US FAERS
646Nail InfectionFAERS: 3US FAERS
647NecrosisFAERS: 3US FAERS
648NeuritisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
649Neuroleptic Malignant SyndromeFAERS: 3US FAERS
650NocturiaFAERS: 3US FAERS
651Nuchal RigidityFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
652OphthalmoplegiaFAERS: 3US FAERS
653Optic AtrophyFAERS: 3US FAERS
654Optic NeuropathyFAERS: 3US FAERS
655Oral fungal infectionFAERS: 3US FAERS
656Oral painFAERS: 3US FAERS
657Oropharyngeal blisteringFAERS: 3US FAERS
658Oropharyngeal swellingFAERS: 3US FAERS
659Oxygen supplementationFAERS: 3US FAERS
660Pancreatic InsufficiencyFAERS: 3US FAERS
661Pancreatic enlargementFAERS: 3US FAERS
662Pelvic PainFAERS: 3US FAERS
663Penile size reducedFAERS: 3US FAERS
664Peripheral artery occlusionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
665PhotophobiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
666Platelet count abnormalFAERS: 3US FAERS
667PolyarthritisFAERS: 3US FAERS
668Post-Traumatic Stress DisorderFAERS: 3US FAERS
669Postinfarction anginaFAERS: 3US FAERS
670Prescription drug used without a prescriptionFAERS: 3US FAERS
671PriapismFAERS: 3US FAERS
672Product container seal issueFAERS: 3US FAERS
673Product difficult to swallowFAERS: 3US FAERS
674Prostatic painFAERS: 3US FAERS
675Pulmonary HypertensionFAERS: 3US FAERS
676Pulmonary InfarctionFAERS: 3US FAERS
677QuadriparesisFAERS: 3US FAERS
678RadiculitisFAERS: 3US FAERS
679RadiculopathyFAERS: 3US FAERS
680Retinal Vein OcclusionFAERS: 3US FAERS
681RhinitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
682Senile dementiaFAERS: 3US FAERS
683Skeletal injuryFAERS: 3US FAERS
684Sleep disorder due to general medical condition, insomnia typeFAERS: 3US FAERS
685Spinal column injuryFAERS: 3US FAERS
686SpondylolisthesisFAERS: 3US FAERS
687Squamous cell carcinomaFAERS: 3US FAERS
688Sudden Cardiac DeathFAERS: 3US FAERS
689SunburnFAERS: 3US FAERS
690Supraventricular tachycardiaFAERS: 3US FAERS
691SynovitisFAERS: 3US FAERS
692TachyarrhythmiaFAERS: 3US FAERS
693TenosynovitisFAERS: 3US FAERS
694TetanyFAERS: 3US FAERS
695Therapeutic procedureFAERS: 3US FAERS
696Therapy cessationFAERS: 3US FAERS
697Thermal burnFAERS: 3US FAERS
698ThrombophlebitisFAERS: 3US FAERS
699TrichorrhexisFAERS: 3US FAERS
700TuberculosisFAERS: 3US FAERS
701Urine ketone body presentFAERS: 3US FAERS
702Vascular calcificationFAERS: 3US FAERS
703Vascular painFAERS: 3US FAERS
704Venous InjuryFAERS: 3US FAERS
705Violence-related symptomFAERS: 3US FAERS
706angiogramFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
707furuncleFAERS: 3US FAERS
708prostatitisFAERS: 3US FAERS
709Aborted pregnancyFAERS: 2US FAERS
710AcarodermatitisFAERS: 2US FAERS
711AdenocarcinomaFAERS: 2US FAERS
712Ammonia increasedFAERS: 2US FAERS
713Amnestic DisorderFAERS: 2US FAERS
714Anal FissureFAERS: 2US FAERS
715AnencephalyFAERS: 2US FAERS
716Antinuclear antibody increasedFAERS: 2US FAERS
717AnuriaFAERS: 2US FAERS
718Aortic occlusionFAERS: 2US FAERS
719Atrial FlutterFAERS: 2US FAERS
720Autonomic nervous system imbalanceFAERS: 2US FAERS
721Bacteria blood identifiedFAERS: 2US FAERS
722Biliary cirrhosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
723BlepharospasmFAERS: 2US FAERS
724Blood albumin decreasedFAERS: 2US FAERS
725Blood bilirubin abnormalFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
726Blood brain barrier defectFAERS: 2US FAERS
727Blood chloride decreasedFAERS: 2US FAERS
728Blood creatinine abnormalFAERS: 2US FAERS
729Blood glucose normalFAERS: 2US FAERS
730Blood ketone body increasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
731Blood lactate dehydrogenase abnormalFAERS: 2US FAERS
732Blood pressure inadequately controlledFAERS: 2US FAERS
733Blood sodium increasedFAERS: 2US FAERS
734Blood thyroid stimulating hormone abnormalFAERS: 2US FAERS
735Blood zinc decreasedFAERS: 2US FAERS
736Brain scan abnormalFAERS: 2US FAERS
737C-reactive protein decreasedFAERS: 2US FAERS
738CalcinosisFAERS: 2US FAERS
739CandidiasisFAERS: 2US FAERS
740Cardiac HypertrophyFAERS: 2US FAERS
741Carnitine decreasedFAERS: 2US FAERS
742CatarrhFAERS: 2US FAERS
743Cerebral PalsyFAERS: 2US FAERS
744Cerebral atrophyFAERS: 2US FAERS
745Cerebral microhaemorrhageFAERS: 2US FAERS
746Cerebral ventricle dilatationFAERS: 2US FAERS
747Cervix carcinomaFAERS: 2US FAERS
748Cholangiectasis acquiredFAERS: 2US FAERS
749CholangiocarcinomaFAERS: 2US FAERS
750Cholecystitis infectiveFAERS: 2US FAERS
751ChondromatosisFAERS: 2US FAERS
752ChoreaFAERS: 2US FAERS
753Cleft PalateFAERS: 2US FAERS
754ColectomyFAERS: 2US FAERS
755Complications of maternal exposure to therapeutic drugsFAERS: 2US FAERS
756Compression fractureFAERS: 2US FAERS
757Conversion disorderFAERS: 2US FAERS
758Denervation atrophyFAERS: 2US FAERS
759DiverticulumFAERS: 2US FAERS
760DysenteryFAERS: 2US FAERS
761Ejection Fraction DecreasedFAERS: 2US FAERS
762Electromyogram abnormalFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
763EmpyemaFAERS: 2US FAERS
764EnteritisFAERS: 2US FAERS
765Enzyme level increasedFAERS: 2US FAERS
766Epididymal infectionFAERS: 2US FAERS
767Epigastric discomfortFAERS: 2US FAERS
768ErysipelasFAERS: 2US FAERS
769Erythema MultiformeFAERS: 2US FAERS
770Exposure to toxic agentFAERS: 2US FAERS
771Extra dose administeredFAERS: 2US FAERS
772Extranodal marginal zone B-cell lymphoma (MALT type)FAERS: 2US FAERS
773Extraocular Muscle ParesisFAERS: 2US FAERS
774Eye InfectionFAERS: 2US FAERS
775Facial paralysisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
776Fascial ruptureFAERS: 2US FAERS
777Feeling of body temperature changeFAERS: 2US FAERS
778Feelings of worthlessnessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
779Femoral artery occlusionFAERS: 2US FAERS
780Fibroadenoma of breastFAERS: 2US FAERS
781Food PoisoningFAERS: 2US FAERS
782GammopathyFAERS: 2US FAERS
783GangreneFAERS: 2US FAERS
784Gastric DilatationFAERS: 2US FAERS
785Gastrointestinal motility disorderFAERS: 2US FAERS
786Genital HerpesFAERS: 2US FAERS
787Gluten sensitivityFAERS: 2US FAERS
788Growth retardationFAERS: 2US FAERS
789Hallucinations, mixedFAERS: 2US FAERS
790Helicobacter test positiveFAERS: 2US FAERS
791Hepatitis AFAERS: 2US FAERS
792Hepatitis B positiveFAERS: 2US FAERS
793Hepatitis BFAERS: 2US FAERS
794Hepatitis C positiveFAERS: 2US FAERS
795Hernia obstructiveFAERS: 2US FAERS
796HoarsenessFAERS: 2US FAERS
797HyperlipasaemiaFAERS: 2US FAERS
798HyperphagiaFAERS: 2US FAERS
799HyperreflexiaFAERS: 2US FAERS
800HysterectomyFAERS: 2US FAERS
801Iatrogenic injuryFAERS: 2US FAERS
802Idiosyncratic drug reactionFAERS: 2US FAERS
803IleusFAERS: 2US FAERS
804Impaired insulin secretionFAERS: 2US FAERS
805Impaired self-careFAERS: 2US FAERS
806Implantable defibrillator insertionFAERS: 2US FAERS
807Incision site painFAERS: 2US FAERS
808IncoherentFAERS: 2US FAERS
809Infectious MononucleosisFAERS: 2US FAERS
810Intentional self-injuryFAERS: 2US FAERS
811Intermittent ClaudicationFAERS: 2US FAERS
812Intestinal PerforationFAERS: 2US FAERS
813Iron deficiencyFAERS: 2US FAERS
814Joint sprainFAERS: 2US FAERS
815Joint warmthFAERS: 2US FAERS
816Keratoconjunctivitis SiccaFAERS: 2US FAERS
817KetonuriaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
818Lack of spontaneous speechFAERS: 2US FAERS
819Large intestine perforationFAERS: 2US FAERS
820LaryngospasmFAERS: 2US FAERS
821Libido disorderFAERS: 2US FAERS
822Limb massFAERS: 2US FAERS
823Lipoprotein (a) abnormalFAERS: 2US FAERS
824Lymphocyte percentage decreasedFAERS: 2US FAERS
825MELAS SyndromeFAERS: 2US FAERS
826Male Orgasmic DisorderFAERS: 2US FAERS
827Malignant neoplasm of ampulla of VaterFAERS: 2US FAERS
828MalocclusionFAERS: 2US FAERS
829Maternal exposure during pregnancyFAERS: 2US FAERS
830MenopauseFAERS: 2US FAERS
831MetamorphopsiaFAERS: 2US FAERS
832Metastatic NeoplasmFAERS: 2US FAERS
833Milk AllergyFAERS: 2US FAERS
834Mitochondrial DNA mutationFAERS: 2US FAERS
835Monocyte count increasedFAERS: 2US FAERS
836Muscle SpasticityFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
837Muscle tone disorderFAERS: 2US FAERS
838Muscular DystrophyFAERS: 2US FAERS
839Myasthenic SyndromeFAERS: 2US FAERS
840MyelofibrosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
841MyoclonusFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
842MyoglobinaemiaFAERS: 2US FAERS
843MyotoniaFAERS: 2US FAERS
844Nasal PolypsFAERS: 2US FAERS
845NephrectomyFAERS: 2US FAERS
846NephritisFAERS: 2US FAERS
847Nerve DegenerationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
848NeurodermatitisFAERS: 2US FAERS
849NeuromaFAERS: 2US FAERS
850No reaction on previous exposure to drugFAERS: 2US FAERS
851Nodular rashFAERS: 2US FAERS
852Obesity surgeryFAERS: 2US FAERS
853ObstructionFAERS: 2US FAERS
854Occult blood positiveFAERS: 2US FAERS
855OnycholysisFAERS: 2US FAERS
856Oral candidiasisFAERS: 2US FAERS
857Oral pruritusFAERS: 2US FAERS
858OrchitisFAERS: 2US FAERS
859Oropharyngeal discomfortFAERS: 2US FAERS
860Oropharyngeal spasmFAERS: 2US FAERS
861Paranasal sinus hypersecretionFAERS: 2US FAERS
862ParanoiaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
863PemphigusFAERS: 2US FAERS
864Penile blisterFAERS: 2US FAERS
865Percutaneous Coronary InterventionFAERS: 2US FAERS
866Peripheral paralysisFAERS: 2US FAERS
867Peripheral venous diseaseFAERS: 2US FAERS
868Pharyngolaryngeal PainFAERS: 2US FAERS
869PneumonitisFAERS: 2US FAERS
870Polyarteritis NodosaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
871PolydipsiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
872Poor quality product administeredFAERS: 2US FAERS
873Portal fibrosisFAERS: 2US FAERS
874PresbyopiaFAERS: 2US FAERS
875Primary Biliary CholangitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
876Procedural site reactionFAERS: 2US FAERS
877Product contaminationFAERS: 2US FAERS
878Product label issueFAERS: 2US FAERS
879Product residue presentFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
880Progressive supranuclear palsyFAERS: 2US FAERS
881Prosthesis ImplantationFAERS: 2US FAERS
882Protein total increasedFAERS: 2US FAERS
883PseudocystFAERS: 2US FAERS
884Pubic painFAERS: 2US FAERS
885Pulmonary congestionFAERS: 2US FAERS
886PurpuraFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
887Pustular psoriasisFAERS: 2US FAERS
888Renal Cell CarcinomaFAERS: 2US FAERS
889Respiratory muscle weaknessFAERS: 2US FAERS
890Reticulocyte count increasedFAERS: 2US FAERS
891Rheumatic FeverFAERS: 2US FAERS
892Rheumatoid factor increasedFAERS: 2US FAERS
893Saliva alteredFAERS: 2US FAERS
894Sinus ArrhythmiaFAERS: 2US FAERS
895Sinus bradycardiaFAERS: 2US FAERS
896Skin WrinklingFAERS: 2US FAERS
897Skin discomfortFAERS: 2US FAERS
898Skin hypertrophyFAERS: 2US FAERS
899Skin lacerationFAERS: 2US FAERS
900Skin necrosisFAERS: 2US FAERS
901Sputum retentionFAERS: 2US FAERS
902Stent occlusionFAERS: 2US FAERS
903StillbirthFAERS: 2US FAERS
904Stomach scan abnormalFAERS: 2US FAERS
905Stress at workFAERS: 2US FAERS
906Temperature regulation disorderFAERS: 2US FAERS
907Temporal ArteritisFAERS: 2US FAERS
908Terminal stateFAERS: 2US FAERS
909Thrombocytopenic purpuraFAERS: 2US FAERS
910Thyroid cancer metastaticFAERS: 2US FAERS
911ThyroidectomyFAERS: 2US FAERS
912TorticollisFAERS: 2US FAERS
913TrismusFAERS: 2US FAERS
914Unequal Limb LengthFAERS: 2US FAERS
915Upper motor neurone lesionFAERS: 2US FAERS
916Upper respiratory tract congestionFAERS: 2US FAERS
917Upper-airway cough syndromeFAERS: 2US FAERS
918Urine bilirubin increasedFAERS: 2US FAERS
919Uterine CancerFAERS: 2US FAERS
920Vascular insufficiencyFAERS: 2US FAERS
921Vascular stenosisFAERS: 2US FAERS
922Vasculitic rashFAERS: 2US FAERS
923Ventricular FibrillationFAERS: 2US FAERS
924Ventricular failureFAERS: 2US FAERS
925Ventricular hypokinesiaFAERS: 2US FAERS
926Viral upper respiratory tract infectionFAERS: 2US FAERS
927Vulvovaginal pruritusFAERS: 2US FAERS
928White blood cell count abnormalFAERS: 2US FAERS
929effusionFAERS: 2US FAERS
930treatment failureFAERS: 2US FAERS
931Abdominal InfectionFAERS: 1US FAERS
932Abdominal rigidityFAERS: 1US FAERS
933Abdominal tendernessFAERS: 1US FAERS
934Accidental deathFAERS: 1US FAERS
935Accidental exposure to product by childFAERS: 1US FAERS
936Accidental exposureFAERS: 1US FAERS
937Accidental underdoseFAERS: 1US FAERS
938AcidosisFAERS: 1US FAERS
939Actinic keratosisFAERS: 1US FAERS
940Adjustment disorder with depressed moodFAERS: 1US FAERS
941AdrenalectomyFAERS: 1US FAERS
942AgoraphobiaFAERS: 1US FAERS
943AkinesiaFAERS: 1US FAERS
944Albumin globulin ratio decreasedFAERS: 1US FAERS
945Alcohol interactionFAERS: 1US FAERS
946Alcohol withdrawal syndromeFAERS: 1US FAERS
947Aldolase abnormalFAERS: 1US FAERS
948Aldolase decreasedFAERS: 1US FAERS
949Allergy to chemicalsFAERS: 1US FAERS
950AllodyniaFAERS: 1US FAERS
951Alpha hydroxybutyrate dehydrogenase increasedFAERS: 1US FAERS
952Alpha-1 anti-trypsin increasedFAERS: 1US FAERS
953Amino acid level decreasedFAERS: 1US FAERS
954AmyloidosisFAERS: 1US FAERS
955Anal abscessFAERS: 1US FAERS
956Anaphylactic shockFAERS: 1US FAERS
957Anorectal discomfortFAERS: 1US FAERS
958Antiacetylcholine receptor antibody positiveFAERS: 1US FAERS
959Antisocial Personality DisorderFAERS: 1US FAERS
960Aortic embolusFAERS: 1US FAERS
961Apolipoprotein A-I increasedFAERS: 1US FAERS
962Apolipoprotein abnormalFAERS: 1US FAERS
963ApoptosisFAERS: 1US FAERS
964Apparent life threatening eventFAERS: 1US FAERS
965Arterial stenosis limbFAERS: 1US FAERS
966Aspartate aminotransferase abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
967Atrioventricular Septal DefectFAERS: 1US FAERS
968Atrophic vulvovaginitisFAERS: 1US FAERS
969Bacterial test positiveFAERS: 1US FAERS
970BacteriuriaFAERS: 1US FAERS
971Basal ganglion degenerationFAERS: 1US FAERS
972Bile Duct StenosisFAERS: 1US FAERS
973Bile duct necrosisFAERS: 1US FAERS
974Biliary ColicFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
975Biliary DyskinesiaFAERS: 1US FAERS
976Biliary polypFAERS: 1US FAERS
977Biopsy bone abnormalFAERS: 1US FAERS
978Biopsy brain abnormalFAERS: 1US FAERS
979Biopsy skin abnormalFAERS: 1US FAERS
980Bipolar I disorderFAERS: 1US FAERS
981Bladder NeoplasmFAERS: 1US FAERS
982Bladder cancer recurrentFAERS: 1US FAERS
983Bladder discomfortFAERS: 1US FAERS
984Bladder prolapseFAERS: 1US FAERS
985BlepharitisFAERS: 1US FAERS
986Blood PressureFAERS: 1US FAERS
987Blood acid phosphatase decreasedFAERS: 1US FAERS
988Blood albumin abnormalFAERS: 1US FAERS
989Blood albumin increasedFAERS: 1US FAERS
990Blood alcohol increasedFAERS: 1US FAERS
991Blood alkaline phosphatase abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
992Blood alkaline phosphataseFAERS: 1US FAERS
993Blood bilirubin decreasedFAERS: 1US FAERS
994Blood bilirubin unconjugated increasedFAERS: 1US FAERS
995Blood calcitonin increasedFAERS: 1US FAERS
996Blood chloride abnormalFAERS: 1US FAERS
997Blood cholesterol esterase increasedFAERS: 1US FAERS
998Blood cholesterolFAERS: 1US FAERS
999Blood copper increasedFAERS: 1US FAERS
1000Blood creatine abnormalFAERS: 1US FAERS
1001Blood creatine phosphokinase decreasedFAERS: 1US FAERS
1002Blood creatineFAERS: 1US FAERS
1003Blood creatinine decreasedFAERS: 1US FAERS
1004Blood electrolytes increasedFAERS: 1US FAERS
1005Blood homocysteine increasedFAERS: 1US FAERS
1006Blood immunoglobulin M increasedFAERS: 1US FAERS
1007Blood magnesium increasedFAERS: 1US FAERS
1008Blood parathyroid hormone decreasedFAERS: 1US FAERS
1009Blood parathyroid hormone increasedFAERS: 1US FAERS
1010Blood phosphorus decreasedFAERS: 1US FAERS
1011Blood phosphorus increasedFAERS: 1US FAERS
1012Blood urea abnormalFAERS: 1US FAERS
1013Blue Toe SyndromeFAERS: 1US FAERS
1014Body fat disorderFAERS: 1US FAERS
1015Bone density abnormalFAERS: 1US FAERS
1016Bone fissureFAERS: 1US FAERS
1017Bone marrow depressionFAERS: 1US FAERS
1018Brain ContusionFAERS: 1US FAERS
1019Brain HypoxiaFAERS: 1US FAERS
1020Brain natriuretic peptide increasedFAERS: 1US FAERS
1021Breakthrough PainFAERS: 1US FAERS
1022Breast cancer recurrentFAERS: 1US FAERS
1023Breath alcohol test positiveFAERS: 1US FAERS
1024Breathing-related sleep disorderFAERS: 1US FAERS
1025Bronchial ObstructionFAERS: 1US FAERS
1026Bronchopulmonary AspergillosisFAERS: 1US FAERS
1027Bronchopulmonary diseaseFAERS: 1US FAERS
1028Bunion operationFAERS: 1US FAERS
1029BunionFAERS: 1US FAERS
1030Burning Mouth SyndromeFAERS: 1US FAERS
1031CD30 expressionFAERS: 1US FAERS
1032Calcium deficiencyFAERS: 1US FAERS
1033Cancer PainFAERS: 1US FAERS
1034Cardiac enzymes increasedFAERS: 1US FAERS
1035Cardiac infectionFAERS: 1US FAERS
1036Cardiac monitoring abnormalFAERS: 1US FAERS
1037Cardioactive drug level decreasedFAERS: 1US FAERS
1038Cardiovascular insufficiencyFAERS: 1US FAERS
1039CarditisFAERS: 1US FAERS
1040Carotid bruitFAERS: 1US FAERS
1041Cartilage atrophyFAERS: 1US FAERS
1042Cartilage injuryFAERS: 1US FAERS
1043Cataract operation complicationFAERS: 1US FAERS
1044Central nervous system lesionFAERS: 1US FAERS
1045Cerebrovascular InsufficiencyFAERS: 1US FAERS
1046CervicectomyFAERS: 1US FAERS
1047CheilitisFAERS: 1US FAERS
1048Chest wall painFAERS: 1US FAERS
1049Choking sensationFAERS: 1US FAERS
1050CholecystostomyFAERS: 1US FAERS
1051Cholestatic liver injuryFAERS: 1US FAERS
1052ChorioretinitisFAERS: 1US FAERS
1053ChromatopsiaFAERS: 1US FAERS
1054Chromosomal mutationFAERS: 1US FAERS
1055Chronic sinusitisFAERS: 1US FAERS
1056Circumstance or information capable of leading to device use errorFAERS: 1US FAERS
1057ClaustrophobiaFAERS: 1US FAERS
1058Clostridium difficile sepsisFAERS: 1US FAERS
1059ClubbingFAERS: 1US FAERS
1060Coagulation factor V level decreasedFAERS: 1US FAERS
1061Coagulation test abnormalFAERS: 1US FAERS
1062Coating in mouthFAERS: 1US FAERS
1063Collagen-vascular diseaseFAERS: 1US FAERS
1064Collateral CirculationFAERS: 1US FAERS
1065Colon adenomaFAERS: 1US FAERS
1066Congenital brain damageFAERS: 1US FAERS
1067Congenital diaphragmatic herniaFAERS: 1US FAERS
1068Contraindicated drug administeredFAERS: 1US FAERS
1069CraniorachischisisFAERS: 1US FAERS
1070CraniosynostosisFAERS: 1US FAERS
1071Creatine phosphokinase decreasedFAERS: 1US FAERS
1072Creatine urine increasedFAERS: 1US FAERS
1073Creatinine renal clearance increasedFAERS: 1US FAERS
1074Cyst removalFAERS: 1US FAERS
1075Cytomegalovirus test positiveFAERS: 1US FAERS
1076CytopeniaFAERS: 1US FAERS
1077Deafness PermanentFAERS: 1US FAERS
1078Death of relativeFAERS: 1US FAERS
1079Decreased immune responsivenessFAERS: 1US FAERS
1080Decreased vibratory senseFAERS: 1US FAERS
1081Dental examination abnormalFAERS: 1US FAERS
1082Dental prosthesis placementFAERS: 1US FAERS
1083Denture wearerFAERS: 1US FAERS
1084DependenceFAERS: 1US FAERS
1085Dermatitis HerpetiformisFAERS: 1US FAERS
1086Detachment of retinal pigment epitheliumFAERS: 1US FAERS
1087Device dislocationFAERS: 1US FAERS
1088Diabetes InsipidusFAERS: 1US FAERS
1089Diabetic glaucomaFAERS: 1US FAERS
1090Diabetic metabolic decompensationFAERS: 1US FAERS
1091Diaphragmatic HerniaFAERS: 1US FAERS
1092Diastolic dysfunctionFAERS: 1US FAERS
1093Disease complicationFAERS: 1US FAERS
1094Dissociative disorderFAERS: 1US FAERS
1095Disturbance in sexual arousalFAERS: 1US FAERS
1096Double vessel bypass graftFAERS: 1US FAERS
1097Drug label confusionFAERS: 1US FAERS
1098Drug level increasedFAERS: 1US FAERS
1099Drug resistanceFAERS: 1US FAERS
1100Drug screen false positiveFAERS: 1US FAERS
1101Drug screen positiveFAERS: 1US FAERS
1102Drug therapy changedFAERS: 1US FAERS
1103Duodenal UlcerFAERS: 1US FAERS
1104Duodenal papillitisFAERS: 1US FAERS
1105Duodenogastric RefluxFAERS: 1US FAERS
1106DyslexiaFAERS: 1US FAERS
1107DysmorphismFAERS: 1US FAERS
1108Eating disorder symptomFAERS: 1US FAERS
1109Echocardiogram abnormalFAERS: 1US FAERS
1110Electrocardiogram QT interval abnormalFAERS: 1US FAERS
1111Electrocardiogram ST segment abnormalFAERS: 1US FAERS
1112Electrocardiogram ST-T segment abnormalFAERS: 1US FAERS
1113Electrolyte imbalanceFAERS: 1US FAERS
1114EndarterectomyFAERS: 1US FAERS
1115EndocarditisFAERS: 1US FAERS
1116Endocrine test abnormalFAERS: 1US FAERS
1117Endodontic procedureFAERS: 1US FAERS
1118Endotracheal intubation complicationFAERS: 1US FAERS
1119Eosinophil percentage increasedFAERS: 1US FAERS
1120Eosinophilic PneumoniaFAERS: 1US FAERS
1121Epidermal necrosisFAERS: 1US FAERS
1122EpiglottitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1123Erythema NodosumFAERS: 1US FAERS
1124Essential TremorFAERS: 1US FAERS
1125EuthanasiaFAERS: 1US FAERS
1126Exercise capacity decreasedFAERS: 1US FAERS
1127Exposure during breast feedingFAERS: 1US FAERS
1128Exposure via partnerFAERS: 1US FAERS
1129Eye allergyFAERS: 1US FAERS
1130Eyelid Function DisorderFAERS: 1US FAERS
1131Eyelid painFAERS: 1US FAERS
1132Eyelids pruritusFAERS: 1US FAERS
1133FasciitisFAERS: 1US FAERS
1134FasciotomyFAERS: 1US FAERS
1135Fat necrosisFAERS: 1US FAERS
1136Fat redistributionFAERS: 1US FAERS
1137Femoral arterial stenosisFAERS: 1US FAERS
1138Fingerprint lossFAERS: 1US FAERS
1139Fluid imbalanceFAERS: 1US FAERS
1140Foaming at mouthFAERS: 1US FAERS
1141Food aversionFAERS: 1US FAERS
1142Food cravingFAERS: 1US FAERS
1143Foreign body aspirationFAERS: 1US FAERS
1144Foreign body in respiratory tractFAERS: 1US FAERS
1145Frontotemporal dementiaFAERS: 1US FAERS
1146Frustration tolerance decreasedFAERS: 1US FAERS
1147Full blood count decreasedFAERS: 1US FAERS
1148Full blood count increasedFAERS: 1US FAERS
1149GalactostasisFAERS: 1US FAERS
1150GastrectomyFAERS: 1US FAERS
1151Gastrointestinal bacterial infectionFAERS: 1US FAERS
1152Gastrointestinal hypermotilityFAERS: 1US FAERS
1153Gastrointestinal mucosal disorderFAERS: 1US FAERS
1154Gastrointestinal obstructionFAERS: 1US FAERS
1155Gastrointestinal perforationFAERS: 1US FAERS
1156Genital painFAERS: 1US FAERS
1157Genital rashFAERS: 1US FAERS
1158Gestational DiabetesFAERS: 1US FAERS
1159GiardiasisFAERS: 1US FAERS
1160Gingival RecessionFAERS: 1US FAERS
1161GingivitisFAERS: 1US FAERS
1162Glaucoma surgeryFAERS: 1US FAERS
1163GlycosuriaFAERS: 1US FAERS
1164Granuloma AnnulareFAERS: 1US FAERS
1165Granulomatosis with polyangiitisFAERS: 1US FAERS
1166GranulomaFAERS: 1US FAERS
1167Growth failureFAERS: 1US FAERS
1168HaematotoxicityFAERS: 1US FAERS
1169Hearing aid userFAERS: 1US FAERS
1170Heart valve stenosisFAERS: 1US FAERS
1171Heat ExhaustionFAERS: 1US FAERS
1172Hepatic InfectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1173Hepatic cancer metastaticFAERS: 1US FAERS
1174Hepatic cancer stage IVFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1175Hepatitis B antibody positiveFAERS: 1US FAERS
1176Hepatitis B virus test positiveFAERS: 1US FAERS
1177Hepatitis viral test positiveFAERS: 1US FAERS
1178Hepatorenal SyndromeFAERS: 1US FAERS
1179Histiocytosis haematophagicFAERS: 1US FAERS
1180Human EhrlichiosisFAERS: 1US FAERS
1181HydrocephalusFAERS: 1US FAERS
1182HydrometraFAERS: 1US FAERS
1183HyperacusisFAERS: 1US FAERS
1184HyperchlorhydriaFAERS: 1US FAERS
1185HyperkinesiaFAERS: 1US FAERS
1186Hypermobility syndromeFAERS: 1US FAERS
1187Hyperplastic cholecystopathyFAERS: 1US FAERS
1188Hypertensive crisisFAERS: 1US FAERS
1189Hypertensive emergencyFAERS: 1US FAERS
1190HypertrichosisFAERS: 1US FAERS
1191HypertrophyFAERS: 1US FAERS
1192Hypoaesthesia of genital maleFAERS: 1US FAERS
1193Hypoplastic Left Heart SyndromeFAERS: 1US FAERS
1194HypospadiasFAERS: 1US FAERS
1195HypotrichosisFAERS: 1US FAERS
1196Idiopathic urticariaFAERS: 1US FAERS
1197Immune thrombocytopenic purpuraFAERS: 1US FAERS
1198ImmunosuppressionFAERS: 1US FAERS
1199Impaired quality of lifeFAERS: 1US FAERS
1200ImpatienceFAERS: 1US FAERS
1201Incision site complicationFAERS: 1US FAERS
1202Incorrect product storageFAERS: 1US FAERS
1203Incorrect storage of drugFAERS: 1US FAERS
1204Infectious pleural effusionFAERS: 1US FAERS
1205Infective tenosynovitisFAERS: 1US FAERS
1206Inflammatory marker increasedFAERS: 1US FAERS
1207Inhibitory drug interactionFAERS: 1US FAERS
1208Insulin ResistanceFAERS: 1US FAERS
1209Intervertebral disc compressionFAERS: 1US FAERS
1210Intervertebral disc injuryFAERS: 1US FAERS
1211Intestinal adenocarcinomaFAERS: 1US FAERS
1212Intestinal cystFAERS: 1US FAERS
1213Intestinal gangreneFAERS: 1US FAERS
1214Intestinal resectionFAERS: 1US FAERS
1215Intracranial massFAERS: 1US FAERS
1216Investigation abnormalFAERS: 1US FAERS
1217Joint abscessFAERS: 1US FAERS
1218KeratitisFAERS: 1US FAERS
1219Labile blood pressureFAERS: 1US FAERS
1220Lacrimal duct procedureFAERS: 1US FAERS
1221Lacrimal structure injuryFAERS: 1US FAERS
1222Lacrimation decreasedFAERS: 1US FAERS
1223Large intestine anastomosisFAERS: 1US FAERS
1224LazinessFAERS: 1US FAERS
1225LentigoFAERS: 1US FAERS
1226Leukocytoclastic vasculitisFAERS: 1US FAERS
1227LeukoplakiaFAERS: 1US FAERS
1228Life expectancy shortenedFAERS: 1US FAERS
1229Ligament painFAERS: 1US FAERS
1230Limb fractureFAERS: 1US FAERS
1231Lip neoplasm malignant stage unspecifiedFAERS: 1US FAERS
1232Loss of proprioceptionFAERS: 1US FAERS
1233Lumbar radiculopathyFAERS: 1US FAERS
1234Lupus NephritisFAERS: 1US FAERS
1235LymphadenitisFAERS: 1US FAERS
1236Lymphocyte count increasedFAERS: 1US FAERS
1237Lymphocyte stimulation test negativeFAERS: 1US FAERS
1238LymphocytosisFAERS: 1US FAERS
1239Lymphoma operationFAERS: 1US FAERS
1240Lymphomatoid PapulosisFAERS: 1US FAERS
1241MacroglossiaFAERS: 1US FAERS
1242Malignant Fibrous HistiocytomaFAERS: 1US FAERS
1243Malignant neoplasm of thoraxFAERS: 1US FAERS
1244Malignant tumour excisionFAERS: 1US FAERS
1245MalnutritionFAERS: 1US FAERS
1246Mass excisionFAERS: 1US FAERS
1247Mastication disorderFAERS: 1US FAERS
1248MastitisFAERS: 1US FAERS
1249Mechanical ventilationFAERS: 1US FAERS
1250Medial Tibial Stress SyndromeFAERS: 1US FAERS
1251Medical device implantationFAERS: 1US FAERS
1252MeningiomaFAERS: 1US FAERS
1253MeningoceleFAERS: 1US FAERS
1254Meniscus removalFAERS: 1US FAERS
1255Mental RetardationFAERS: 1US FAERS
1256Metastases to abdominal cavityFAERS: 1US FAERS
1257Metastases to larynxFAERS: 1US FAERS
1258Metastases to thoraxFAERS: 1US FAERS
1259Metastatic Renal Cell CarcinomaFAERS: 1US FAERS
1260MetatarsalgiaFAERS: 1US FAERS
1261Micturition frequency decreasedFAERS: 1US FAERS
1262Miscarriage of partnerFAERS: 1US FAERS
1263Mitochondrial cytopathyFAERS: 1US FAERS
1264Mitochondrial myopathy acquiredFAERS: 1US FAERS
1265Mixed liver injuryFAERS: 1US FAERS
1266MoaningFAERS: 1US FAERS
1267Monocyte count decreasedFAERS: 1US FAERS
1268MonoparesisFAERS: 1US FAERS
1269Motion SicknessFAERS: 1US FAERS
1270MutismFAERS: 1US FAERS
1271MyelitisFAERS: 1US FAERS
1272Myoclonic EpilepsyFAERS: 1US FAERS
1273Myoglobin blood presentFAERS: 1US FAERS
1274Myositis OssificansFAERS: 1US FAERS
1275Nasal inflammationFAERS: 1US FAERS
1276Negative thoughtsFAERS: 1US FAERS
1277Neonatal disorderFAERS: 1US FAERS
1278Nerve Root CompressionFAERS: 1US FAERS
1279Nerve root lesionFAERS: 1US FAERS
1280Neutrophil percentage increasedFAERS: 1US FAERS
1281Nipple painFAERS: 1US FAERS
1282NystagmusFAERS: 1US FAERS
1283Obsessive-Compulsive DisorderFAERS: 1US FAERS
1284Oculomucocutaneous syndromeFAERS: 1US FAERS
1285OliguriaFAERS: 1US FAERS
1286Open woundFAERS: 1US FAERS
1287Optic disc vascular disorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1288Oral infectionFAERS: 1US FAERS
1289Oxygen ConsumptionFAERS: 1US FAERS
1290PO2 decreasedFAERS: 1US FAERS
1291Painful ejaculationFAERS: 1US FAERS
1292Palmar erythemaFAERS: 1US FAERS
1293Pancreatic FistulaFAERS: 1US FAERS
1294Pancreatic NeoplasmFAERS: 1US FAERS
1295Pancreatic PseudocystFAERS: 1US FAERS
1296ParamnesiaFAERS: 1US FAERS
1297Patent ductus arteriosusFAERS: 1US FAERS
1298Pelvic kidneyFAERS: 1US FAERS
1299Peptic UlcerFAERS: 1US FAERS
1300Performance status decreasedFAERS: 1US FAERS
1301Pericardial effusionFAERS: 1US FAERS
1302Perineal painFAERS: 1US FAERS
1303Peripheral motor neuropathyFAERS: 1US FAERS
1304Peripheral nerve palsyFAERS: 1US FAERS
1305Peripheral occlusive diseaseFAERS: 1US FAERS
1306Peritoneal DialysisFAERS: 1US FAERS
1307Phantom Limb SyndromeFAERS: 1US FAERS
1308Pharyngeal StenosisFAERS: 1US FAERS
1309Pharyngeal swellingFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
1310PharyngitisFAERS: 1US FAERS
1311PityriasisFAERS: 1US FAERS
1312PlagueFAERS: 1US FAERS
1313Pleural InfectionFAERS: 1US FAERS
1314Pleuritic painFAERS: 1US FAERS
1315PleuropericarditisFAERS: 1US FAERS
1316Pocket erosionFAERS: 1US FAERS
1317Portal Vein ThrombosisFAERS: 1US FAERS
1318Portal tract inflammationFAERS: 1US FAERS
1319Post procedural infectionFAERS: 1US FAERS
1320Post procedural painFAERS: 1US FAERS
1321Postoperative adhesionFAERS: 1US FAERS
1322Postoperative infectionFAERS: 1US FAERS
1323Potentiating drug interactionFAERS: 1US FAERS
1324Prescribed underdoseFAERS: 1US FAERS
1325Presenile dementiaFAERS: 1US FAERS
1326Primary HypothyroidismFAERS: 1US FAERS
1327Procalcitonin increasedFAERS: 1US FAERS
1328Product administration errorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1329Product appearance confusionFAERS: 1US FAERS
1330Product availability issueFAERS: 1US FAERS
1331Product blister packaging issueFAERS: 1US FAERS
1332Product coating issueFAERS: 1US FAERS
1333Product comminglingFAERS: 1US FAERS
1334Product complaintFAERS: 1US FAERS
1335Product dose omissionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1336Product expiration date issueFAERS: 1US FAERS
1337Product formulation issueFAERS: 1US FAERS
1338Product label confusionFAERS: 1US FAERS
1339Product name confusionFAERS: 1US FAERS
1340Product package associated injuryFAERS: 1US FAERS
1341Product prescribing errorFAERS: 1US FAERS
1342Product solubility abnormalFAERS: 1US FAERS
1343Product tamperingFAERS: 1US FAERS
1344Progressive Muscular AtrophyFAERS: 1US FAERS
1345Prothrombin time ratio decreasedFAERS: 1US FAERS
1346PseudolymphomaFAERS: 1US FAERS
1347PseudoparalysisFAERS: 1US FAERS
1348Pseudoradicular syndromeFAERS: 1US FAERS
1349Psychological TraumaFAERS: 1US FAERS
1350Psychomotor skills impairedFAERS: 1US FAERS
1351Pulmonary Valve StenosisFAERS: 1US FAERS
1352PurulenceFAERS: 1US FAERS
1353Purulent dischargeFAERS: 1US FAERS
1354PyuriaFAERS: 1US FAERS
1355Radiation dysphagiaFAERS: 1US FAERS
1356Radiation necrosisFAERS: 1US FAERS
1357RalesFAERS: 1US FAERS
1358Recalled product administeredFAERS: 1US FAERS
1359Refusal of treatment by relativeFAERS: 1US FAERS
1360Renal OsteodystrophyFAERS: 1US FAERS
1361Renal artery occlusionFAERS: 1US FAERS
1362Renal tubular disorderFAERS: 1US FAERS
1363Respiratory tract congestionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1364Restrictive pulmonary diseaseFAERS: 1US FAERS
1365Rheumatic disorderFAERS: 1US FAERS
1366RhinalgiaFAERS: 1US FAERS
1367SacroiliitisFAERS: 1US FAERS
1368SarcomaFAERS: 1US FAERS
1369ScabFAERS: 1US FAERS
1370SchizophreniaFAERS: 1US FAERS
1371Seizure like phenomenaFAERS: 1US FAERS
1372Semen abnormalFAERS: 1US FAERS
1373Semen volume abnormalFAERS: 1US FAERS
1374Semen volume increasedFAERS: 1US FAERS
1375Sinus polypFAERS: 1US FAERS
1376Skin PapillomaFAERS: 1US FAERS
1377Sleep TalkingFAERS: 1US FAERS
1378Sleep disorder due to general medical condition, mixed typeFAERS: 1US FAERS
1379Slow response to stimuliFAERS: 1US FAERS
1380Small intestine carcinomaFAERS: 1US FAERS
1381SnoringFAERS: 1US FAERS
1382SoliloquyFAERS: 1US FAERS
1383Sperm count decreasedFAERS: 1US FAERS
1384Spermatozoa abnormalFAERS: 1US FAERS
1385Spina Bifida OccultaFAERS: 1US FAERS
1386Spina BifidaFAERS: 1US FAERS
1387Spinal Muscular AtrophyFAERS: 1US FAERS
1388Spinal claudicationFAERS: 1US FAERS
1389SpondylolysisFAERS: 1US FAERS
1390SpondylosisFAERS: 1US FAERS
1391StarvationFAERS: 1US FAERS
1392Stool analysis abnormalFAERS: 1US FAERS
1393StrabismusFAERS: 1US FAERS
1394Stroke in evolutionFAERS: 1US FAERS
1395Subcutaneous AbscessFAERS: 1US FAERS
1396Sudden onset of sleepFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1397Symptom maskedFAERS: 1US FAERS
1398Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
1399Systemic lupus erythematosus rashFAERS: 1US FAERS
1400TachyphreniaFAERS: 1US FAERS
1401TachyphylaxisFAERS: 1US FAERS
1402Tarsal Tunnel SyndromeFAERS: 1US FAERS
1403Tendon discomfortFAERS: 1US FAERS
1404Tendon necrosisFAERS: 1US FAERS
1405TetanusFAERS: 1US FAERS
1406Therapeutic product effect incompleteFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
1407Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
1408Therapy regimen changedFAERS: 1US FAERS
1409Thromboangiitis ObliteransFAERS: 1US FAERS
1410ThromboembolectomyFAERS: 1US FAERS
1411ThyroiditisFAERS: 1US FAERS
1412Tinea PedisFAERS: 1US FAERS
1413Tongue cancer recurrentFAERS: 1US FAERS
1414Tongue discomfortFAERS: 1US FAERS
1415Tongue pruritusFAERS: 1US FAERS
1416Tooth AvulsionFAERS: 1US FAERS
1417Tooth ExtractionFAERS: 1US FAERS
1418Tooth InfectionFAERS: 1US FAERS
1419Total bile acids increasedFAERS: 1US FAERS
1420Total cholesterol/HDL ratio decreasedFAERS: 1US FAERS
1421Toxic Epidermal NecrolysisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1422Transaminases abnormalFAERS: 1US FAERS
1423Transcription medication errorFAERS: 1US FAERS
1424Transferrin increasedFAERS: 1US FAERS
1425Traumatic Brain InjuryFAERS: 1US FAERS
1426Traumatic liver injuryFAERS: 1US FAERS
1427Troponin I increasedFAERS: 1US FAERS
1428Troponin T increasedFAERS: 1US FAERS
1429Ultrasound Doppler abnormalFAERS: 1US FAERS
1430UnderweightFAERS: 1US FAERS
1431Unresponsive to stimuliFAERS: 1US FAERS
1432Urea renal clearance decreasedFAERS: 1US FAERS
1433Urinary occult blood positiveFAERS: 1US FAERS
1434Urinary sediment presentFAERS: 1US FAERS
1435Urinary tract obstructionFAERS: 1US FAERS
1436Urine albumin/creatinine ratio increasedFAERS: 1US FAERS
1437Urine flow decreasedFAERS: 1US FAERS
1438Urine leukocyte esterase positiveFAERS: 1US FAERS
1439Urine output increasedFAERS: 1US FAERS
1440Urobilin urine presentFAERS: 1US FAERS
1441UveitisFAERS: 1US FAERS
1442VIIth nerve paralysisFAERS: 1US FAERS
1443Vaginal DischargeFAERS: 1US FAERS
1444Vagus Nerve DisorderFAERS: 1US FAERS
1445Vascular bypass dysfunctionFAERS: 1US FAERS
1446Vascular ruptureFAERS: 1US FAERS
1447Venous stasisFAERS: 1US FAERS
1448Ventricle ruptureFAERS: 1US FAERS
1449Ventricular arrhythmiaFAERS: 1US FAERS
1450Very low density lipoprotein increasedFAERS: 1US FAERS
1451Viral myocarditisFAERS: 1US FAERS
1452Viral pericarditisFAERS: 1US FAERS
1453Vulvovaginal burning sensationFAERS: 1US FAERS
1454Vulvovaginal drynessFAERS: 1US FAERS
1455Vulvovaginal erythemaFAERS: 1US FAERS
1456Vulvovaginal mycotic infectionFAERS: 1US FAERS
1457Vulvovaginal painFAERS: 1US FAERS
1458Vulvovaginal swellingFAERS: 1US FAERS
1459Waist circumference increasedFAERS: 1US FAERS
1460Water IntoxicationFAERS: 1US FAERS
1461Whole blood transfusionFAERS: 1US FAERS
1462Wrong drug administeredFAERS: 1US FAERS
1463Wrong product administeredFAERS: 1US FAERS
1464X-ray abnormalFAERS: 1US FAERS
1465XerophthalmiaFAERS: 1US FAERS
1466XerosisFAERS: 1US FAERS
1467YawningFAERS: 1US FAERS
1468colonoscopyFAERS: 1US FAERS
1469liposarcomaFAERS: 1US FAERS
1470ovarian neoplasmFAERS: 1US FAERS
1471Angiogram abnormalCanada Vigilance: 1Canada Vigilance
1472Aortic bypassCanada Vigilance: 1Canada Vigilance
1473AsterixisCanada Vigilance: 1Canada Vigilance
1474Bilirubin conjugated abnormalCanada Vigilance: 1Canada Vigilance
1475Carotid EndarterectomyCanada Vigilance: 1Canada Vigilance
1476CholedocholithotomyCanada Vigilance: 1Canada Vigilance
1477Clostridium difficile colitisCanada Vigilance: 1Canada Vigilance
1478Colitis psychogenicCanada Vigilance: 1Canada Vigilance
1479Corneal OpacityCanada Vigilance: 1Canada Vigilance
1480Corneal lesionCanada Vigilance: 1Canada Vigilance
1481Counterfeit product administeredCanada Vigilance: 1Canada Vigilance
1482Delusional disorder, persecutory typeCanada Vigilance: 1Canada Vigilance
1483Endometrial adenocarcinomaCanada Vigilance: 1Canada Vigilance
1484Euphoric moodCanada Vigilance: 1Canada Vigilance
1485Gamma-glutamyltransferase abnormalCanada Vigilance: 1Canada Vigilance
1486Gastric pH decreasedCanada Vigilance: 1Canada Vigilance
1487Gastrointestinal ulcerCanada Vigilance: 1Canada Vigilance
1488HungerCanada Vigilance: 1Canada Vigilance
1489Migraine with AuraCanada Vigilance: 1Canada Vigilance
1490Muscle enzyme decreasedCanada Vigilance: 1Canada Vigilance
1491Product used for unknown indicationCanada Vigilance: 1Canada Vigilance
1492Rectal ProlapseCanada Vigilance: 1Canada Vigilance
1493Renal ColicCanada Vigilance: 1Canada Vigilance
1494Semen analysis abnormalCanada Vigilance: 1Canada Vigilance
1495Serum SicknessCanada Vigilance: 1Canada Vigilance
1496Sinonasal obstructionCanada Vigilance: 1Canada Vigilance
1497TalipesCanada Vigilance: 1Canada Vigilance
1498Testis discomfortCanada Vigilance: 1Canada Vigilance
1499Therapeutic response changedCanada Vigilance: 1Canada Vigilance
1500Therapy changeCanada Vigilance: 2Canada Vigilance
1501Total cholesterol/HDL ratio abnormalCanada Vigilance: 1Canada Vigilance
1502Total cholesterol/HDL ratio increasedCanada Vigilance: 1Canada Vigilance
1503Trisomy 21Canada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.